Edition:
United Kingdom

People: Canopy Growth Corp (WEED.TO)

WEED.TO on Toronto Stock Exchange

53.28CAD
21 Jun 2019
Change (% chg)

-- (--)
Prev Close
$53.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,358,657
52-wk High
$76.68
52-wk Low
$31.81

Ware, Mark 

Dr. Mark Ware is Chief Medical Officer of the Company. Dr. Ware is an associate professor of family medicine and anesthesia at McGill University. Over a period of 20 years he has established himself as a dedicated researcher and thought leader in advancing the medical community's understanding of cannabis and cannabinoids. His research has focused on the safety, efficacy and effectiveness of cannabis and cannabinoids in pain and symptom management, and dates back well before the days of commercial cannabis production. He served for 10 years as executive director of the non-profit Canadian Consortium for the Investigation of Cannabinoids (CCIC), and is also a long-standing board member of the International Association for Cannabinoid Medicines. In 2016, Dr. Ware served as vice-chair of the government of Canada's Task Force on Cannabis Legalization and Regulation. Dr. Ware will take a leave of absence from McGill University to pursue this opportunity.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Bruce Linton

2,516,010

Mark Zekulin

2,496,580

Tim Saunders

2,085,450

Rade Kovacevic

2,147,730

Olivier Dufourmantelle

720,298

Mark Ware

--
As Of  31 Mar 2018